WeVote
Log In

Bill

Bill

SB 5915

Concerning the health technology assessment program.

2025-2026 Regular Session Introduced by Mike Chapman and 3 co-sponsors

SB 5915 establishes Washington's health technology assessment program to evaluate medical treatment effectiveness and cost for insurance coverage decisions.

Referred to Rules 2 Review.
0
WeVote Research Nonpartisan
Bill Summary · SB 5915

Legislative bill overview

SB 5915 establishes or modifies Washington state's health technology assessment (HTA) program, which evaluates the clinical effectiveness and cost-effectiveness of medical treatments, devices, and procedures. The bill has advanced through the House Committee on Health Care & Wellness with a "do pass" recommendation and is currently under Rules review for potential floor consideration.

Why is this important

Health technology assessments directly influence which treatments insurance plans cover and how much they reimburse providers, affecting both healthcare access and costs for Washington residents. The program's decisions impact pharmaceutical companies, medical device manufacturers, healthcare providers, and patients seeking coverage for newer or alternative treatments.

Potential points of contention

  • Coverage and access trade-offs: Stringent cost-effectiveness thresholds may limit coverage for expensive treatments, potentially denying patients access to drugs that work but are costly, versus more permissive standards that increase insurance premiums
  • Stakeholder influence: Questions about who sits on assessment committees and how much weight is given to patient advocacy groups, manufacturers, and payers in determining what qualifies as "effective"
  • Implementation details: How the program will interact with existing insurance regulations, Medicaid coverage decisions, and federal requirements; whether recommendations are binding or advisory

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.